Keyphrases
Dopaminergic Neurons
100%
Neurodegeneration
100%
Subthalamic nucleus
100%
Parkinson's Disease
100%
Motor Dysfunction
66%
Parkinsonian
66%
Disease-modifying Therapy
33%
Disease Modification
33%
Isradipine
33%
Parkinson's Disease Model
33%
NINDS
33%
Motor Cortex
33%
Phase III Clinical Trial
33%
CaV1.3 Channels
33%
Substantia Nigra Pars Compacta
33%
External Globus Pallidus
33%
Mouse Model
33%
Activity Patterns
33%
Abnormal Activity
33%
Selective Inhibition
33%
Therapeutic Strategies
33%
Pharmacology, Toxicology and Pharmaceutical Science
Dopamine Receptor Stimulating Agent
100%
Nerve Cell Degeneration
100%
Parkinson's Disease
100%
Motor Dysfunction
66%
Diseases
66%
Isradipine
33%
Clinical Trial
33%
Mouse Model
33%
Biochemistry, Genetics and Molecular Biology
Nerve Cell Degeneration
100%
Dopaminergic
100%
Mouse Model
50%
Clinical Trial
50%
Cav1.3
50%
Isradipine
50%